LOGO
LOGO

BHEL To Pump In Rs.1,300 Cr. In R&D

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Power equipment maker Bharat Heavy Electricals Ltd. (BHEL) is likely to pump in around Rs.1,300 crore towards R&D activities during this fiscal, reports said, quoting General Manager-Corporate R&D S. Sekar.

He said, "During the last year (2012-13), company-wide R&D investment went up to Rs.1,248 crore, which was an increase of four percent over previous year. This year also, the spend will be in the range of four percent over last year's amount."

The products that were developed in-house have contributed Rs 9,643 crore to BHEL's overall turnover last year. Sekar said, adding that the turnover from the in-house developed products and services stood at Rs.9,643 crore, which was around 19 percent of the turnover of the company.

BHEL's R&D division had filed 385 intellectual property rights comprising copyrights and patents last year, taking the overall tally to 2,170 patents and copyrights. The division has nearly 700 engineers and some of the projects and research works are done jointly with academia.

In the utility segment of the state-run company, capacity addition of 9,328 MW has been achieved, surpassing all the previous records, Sekar added.

BHEL's R&D division has nearly 700 engineers and some of the projects and research works are done jointly with academia.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19